FDA PDUFA Calendar

Upcoming FDA drug approval dates, PDUFA target action dates, and biotech catalyst events by ticker.

BiotechSign tracks 38 upcoming FDA PDUFA (Prescription Drug User Fee Act) target action dates for new drug and biologics applications. PDUFA dates represent the FDA's deadline to act on an NDA (New Drug Application) or BLA (Biologics License Application) submission. These dates are among the most significant binary catalysts in biotech investing — an approval or rejection can move a stock 50% or more in a single session. This calendar is checked against new SEC filings every 4 hours, and any date that moves is flagged with the filing that changed it.

Not financial advice. PDUFA dates involve binary FDA outcomes that can result in total loss of investment. Biotech stocks carry extreme risk. Always conduct your own due diligence and consult a qualified financial advisor. Source: BiotechSigns (biotechsign.com).

Next FDA PDUFA Decision Dates

Upcoming FDA calendar events sorted by action date. Click any ticker for the full BiotechSign catalyst profile.

DateTickerCompanyFDA decision / indicationTimingCalendar
Nov 22, 2026CAPRCapricor Therapeutics, Inc.Deramiocel — Duchenne muscular dystrophy (DMD)
1 days
Nov 27, 2026BBIOBridgeBio PharmaBBP-418 — limb-girdle muscular dystrophy type 2I/R9, or LGMD2I/R9
6 days
Nov 30, 2026COGTCogent BiosciencesCOGT (Cogent Biosciences) — PDUFA date
9 days
Nov 30, 2026VRTXVertex Pharmaceuticalspovetacicept — IgAN
9 days
Dec 12, 2026VNDAVanda Pharmaceuticalsimsidolimab — Generalized Pustular Psoriasis
21 days
Dec 12, 2026VNDAVanda PharmaceuticalsQuimilza — Generalized Pustular Psoriasis (GPP)
21 days
Dec 17, 2026CORTCorcept Therapeuticsrelacorilant — Cushing's syndrome
26 days
Dec 22, 2026MLYSMineralys Therapeutics, Inc.Lorundrostat — Adults with Hypertension and Topline Explore-OSA Tr
31 days
Dec 27, 2026PRAXPraxis Precision Medicinerelutrigine — SCN2A and SCN8A DEEs
36 days
Jan 4, 2027NUVBNuvation BioIBTROZI — ROS1-positive non-small cell lung cancer (ROS1+ NSCLC)
44 days
Jan 4, 2027NUVBNuvation BioIBTROZI — ROS1+ NSCLC
44 days
Jan 6, 2027IBRXImmunityBio, Inc.IBRX (ImmunityBio, Inc.) — PDUFA date
46 days

November 2026

Sun
Mon
Tue
Wed
Thu
Fri
Sat
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
28
29

November Events

CAPRPDUFA DATEDeramiocel — Duchenne muscular dystrophy (DMD)in 1 daysNov 22, 2026
BBIOPDUFA DATEBBP-418 — limb-girdle muscular dystrophy type 2I/R9, or LGMD2I/R9in 6 daysNov 27, 2026
COGTPDUFA DATECOGT (Cogent Biosciences) — PDUFA datein 9 daysNov 30, 2026
VRTXPDUFA DATEpovetacicept — IgANin 9 daysNov 30, 2026

Understanding PDUFA Dates

What is a PDUFA date?

PDUFA stands for the Prescription Drug User Fee Act. A PDUFA date is the FDA's self-imposed deadline to complete its review of a New Drug Application (NDA) or Biologics License Application (BLA). Under PDUFA, the FDA commits to a 10-month standard review or 6-month Priority Review action date from the date of filing acceptance. The FDA meets its PDUFA deadline roughly 90% of the time.

What does the FDA actually do on the PDUFA date?

The FDA issues a Complete Response Letter (CRL) if it cannot approve the drug, or an approval letter granting marketing authorization. The agency may also approve with labeling restrictions, a Risk Evaluation and Mitigation Strategy (REMS), or request additional post-marketing studies. The PDUFA date is the last possible action date — the FDA can and often does act earlier.

How are PDUFA dates determined?

Once the FDA accepts a drug application for filing, it sets the PDUFA date at 10 months from the 60-day filing acceptance date (or 6 months for Priority Review). Companies disclose PDUFA dates in SEC filings and press releases. The FDA publishes its own PDUFA calendar. BiotechSign aggregates these from public sources and updates them daily.

What is an ADCOM meeting and how does it relate to PDUFA?

An Advisory Committee (ADCOM) is an independent expert panel the FDA convenes to publicly review an application and provide a non-binding vote. Not every drug gets an ADCOM — the FDA requests one when it wants outside perspective on complex risk-benefit questions. ADCOM meetings typically occur 1–3 months before the PDUFA date. The FDA does not always follow the ADCOM vote but historically approves drugs with positive votes at a high rate.

Can a PDUFA date change?

Yes. The FDA can extend its review by three months if it issues a Complete Response Letter for a major deficiency, or if the sponsor submits a major amendment during the review window. Companies must disclose PDUFA date changes in SEC filings. BiotechSign updates dates when new disclosures are detected.

How does BiotechSign track PDUFA data?

BiotechSign pulls PDUFA dates from SEC filings (8-Ks, 10-Qs, press releases), the FDA's published PDUFA calendar, and ClinicalTrials.gov. Dates are mapped to publicly traded tickers and updated daily. Use the watchlist filter above to focus on tickers you track.

Data from SEC EDGAR, FDA.gov, and ClinicalTrials.gov. Informational purposes only. Not financial advice. PDUFA Guide →

Not financial advice. Data by Guerilla Finance Inc. for informational purposes only. Always conduct your own due diligence.